Key Findings

1 Terminal Hair Counts:

Nutrafol Women's Balance significantly increased terminal hair counts by 4.3% and 10.2% after 90 and 180 days of treatment, respectively. No changes were observed in the placebo group (-0.2% at day 90 and 0.7% at day 180).

2 Total Hair Counts:

Nutrafol Women's Balance significantly increased total hair counts by 3.7% and 9.97% after 90 and 180 days of treatment, respectively. No changes were observed in the placebo group (-0.2% at day 90 and -0.2% at day 180).

3 Vellus Hair Counts:

Nutrafol Women's Balance significantly increased vellus hair counts by 10.78% after 180 days of treatment. No changes were observed in the placebo group (-3.38% at day 180).

4 Hair Shedding:

Nutrafol Women's Balance significantly reduced hair shedding - cumulating in a decrease of -32.41% (P<0.01) after 180 days of treatment. The placebo group exhibited a -10.08% reduction in shedding (statistically insignificant).

5 Blinded Investigator Global Hair Assessments:

A significantly greater proportion of subjects in the Nutrafol Women's Balance group recorded global hair growth improvement ratings after 180 days of treatment, compared to placebo (73% and 22% for Women's Balance and placebo groups, respectively).